Capricor Therapeutics Inc Stock
Capricor Therapeutics Inc gained 0.610% compared to yesterday.
Our community identified positive and negative aspects for Capricor Therapeutics Inc stock for the coming years. 0 users see the criterium "Return on equity" as a plus for the Capricor Therapeutics Inc stock. On the other hand our users think that "Return on equity" could be a problem in the future.
Pros and Cons of Capricor Therapeutics Inc in the next few years
Pros
?
G***** c******* t* c**********
?
B****
?
S********** s********
Cons
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Capricor Therapeutics Inc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Capricor Therapeutics Inc | 0.610% | 3.376% | 425.751% | 81.213% | 80.678% | 584.166% | 637.952% |
| Evolus Inc | -3.390% | 0.000% | -0.840% | -43.810% | -43.810% | -10.606% | 120.561% |
| Lexicon Pharmaceuticals Inc. | -3.200% | 4.724% | -15.832% | 40.811% | 40.811% | -40.647% | -62.746% |
| Krystal Biotech | -0.050% | 4.672% | 13.749% | 39.043% | 41.327% | 190.676% | - |